Sonia Jain

Sonia Jain

Auto-generated profile, based on publicly available information

Sonia Jain

University of California San Diego

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Journal of Neurotrauma
Verified
Journal Article
Closed access
LXLinda B. Xu
Linda B. Xu
John K YueJohn K Yue
John K Yue
FKFrederick Korley
Frederick Korley
APAva M. Puccio
Ava M. Puccio
EYEsther L. Yuh
Esther L. Yuh
RDRamon Diaz-Arrastia
Ramon Diaz-Arrastia
Systemic inflammation impacts outcome after traumatic brain injury (TBI), but most TBI biomarker studies have focused on brain-specific proteins. C-reactive protein (CRP) is a widely used biomarker of inflammation with potential as a prognostic biomarker after TBI. The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study prospectively enrolled TBI patients within 24 h of injury, as well as orthopedic injury and uninjured controls; biospecimens were collected at enrollment. A subset of hospitalized participants had blood collected on day 3, day 5, and 2 weeks. High-sensitivity CRP (hsCRP) and glial fibrillary acidic protein (GFAP) were measured. Receiver operating characteristic analysis was used to evaluate the prognostic ability of hsCRP for 6-month outcome, using the Glasgow Outcome Scale-Extended (GOSE). We included 1206 TBI subjects, 122 orthopedic trauma controls (OTCs), and 209 healthy controls (HCs). Longitudinal biomarker sampling was performed in 254 hospitalized TBI subjects and 19 OTCs. hsCRP rose between days 1 and 5 for TBI and OTC subjects, and fell by 2 weeks, but remained elevated compared with HCs (p < 0.001). Longitudinally, hsCRP was significantly higher in the first 2 weeks for subjects with death/severe disability (GOSE <5) compared with those with moderate disability/good recovery (GOSE ≥5); AUC was highest at 2 weeks (AUC = 0.892). Combining hsCRP and GFAP at 2 weeks produced AUC = 0.939 for prediction of disability. Serum hsCRP measured within 2 weeks of TBI is a prognostic biomarker for disability 6 months later. hsCRP may have utility as a biomarker of target engagement for anti-inflammatory therapies.

1 April 2022 in The Journal of Pediatrics
Verified
Journal Article
Closed access
JYJincheng Yang
Jincheng Yang
SJSonia Jain
Sonia Jain
ECEdmund V. Capparelli
Edmund V. Capparelli
BBBrookie M. Best
Brookie M. Best
MSMary Beth Son
Mary Beth Son
ATAdriana H. Tremoulet
Adriana H. Tremoulet

19 February 2021 in Journal of Neurotrauma
Verified
Journal Article
Closed access
SAStephanie D. Agtarap
Stephanie D. Agtarap
LCLaura Campbell-Sills
Laura Campbell-Sills
SJSonia Jain
Sonia Jain
XSXiaoying Sun
Xiaoying Sun
SDSureyya Dikmen
Sureyya Dikmen
MSMurray B. Stein
Murray B. Stein
Identifying the principal determinants of life satisfaction following mild TBI (mTBI) may inform efforts to improve subjective well-being in this population. We examined life satisfaction among participants in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study who presented with mTBI (Glasgow Coma Scale [GCS] score = 13–15; n = 1152). An L1-regularization path algorithm was used to select optimal sets of baseline and concurrent symptom measures for prediction of scores on the Satisfaction with Life Scale (SWLS) at 2 weeks and 3, 6, and 12 months post-injury. Multi-variable linear regression models (all n = 744–894) were then fit to evaluate associations between the empirically selected predictors and SWLS scores at each follow-up visit. Results indicated that emotional post-TBI symptoms (all b = −1.27 to −0.77, all p < 0.05), anhedonia (all b = −1.59 to −1.08, all p < 0.01), and pain interference (all b = −1.38 to −0.89, all p < 0.001) contributed to the prediction of lower SWLS scores at all follow-ups. Insomnia predicted lower SWLS scores at 2 weeks, 3 months, and 6 months (all b = −1.11 to −0.83, all p s < 0.01); and negative affect predicted lower SWLS scores at 2 weeks, 3 months, and 12 months (all b = −1.38 to −0.80, all p < 0.005). Other post-TBI symptom domains and baseline socio-demographic, injury-related, and clinical characteristics did not emerge as robust predictors of SWLS scores during the year after mTBI. Efforts to improve satisfaction with life following mTBI may benefit from a focus on the detection and treatment of affective symptoms, pain, and insomnia. The results reinforce the need for tailoring of evidence-based treatments for these conditions to maximize efficacy in patients with mTBI.

1 April 2025 in Annals of Internal Medicine
Verified
Journal Article
Closed access
JFJames S. Ford
James S. Ford
JMJoseph C. Morrison
Joseph C. Morrison
MKMay Kyaw
May Kyaw
MHMeghan Hewlett
Meghan Hewlett
PTPeggy Tahir
Peggy Tahir
GWGabriel Wardi
Gabriel Wardi
The Centers for Medicare & Medicaid Services (CMS) Severe Sepsis and Septic Shock Management Bundle (SEP-1) is now included in the Hospital Value-Based Purchasing (VBP) Program. To assess the evidence supporting SEP-1 compliance or SEP-1 implementation in improving sepsis mortality. PubMed, Web of Science, EMBASE, CINAHL Complete, and Cochrane Library from inception to 26 November 2024. Studies of adults with sepsis that included 3- or 6-hour sepsis bundles defined by SEP-1 specifications. Article screening, full-text review, data extraction, and risk-of-bias assessment were independently performed by 2 authors. Level of evidence was determined using GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria and National Quality Forum criteria. A total of 4403 unique references were screened, and 17 studies were included. Twelve studies assessed the relationship between SEP-1 compliance and mortality; 5 showed statistically significant benefit, whereas 7 did not. Among studies showing benefit, 1 did not adjust for confounders, 1 found benefit only among patients with severe sepsis, 1 included only patients with septic shock, and 1 included only Medicare beneficiaries. Five studies assessed the relationship between SEP-1 implementation and sepsis mortality; only 1 showed significant benefit, but it did not adjust for mortality trends before SEP-1 implementation. All 17 studies were observational, and none had low risk of bias. The conclusions are limited by the underlying quality of the available studies, as all were observational. Because there was considerable methodologic heterogeneity among the included studies, a meta-analysis was not performed as the results could have been misleading. This review found no moderate- or high-level evidence to support that compliance with or implementation of SEP-1 was associated with sepsis mortality. CMS should reconsider the addition of SEP-1 to the Hospital VBP Program. None. (PROSPERO: CRD42023482787).

1 October 2021 in Biological Psychiatry
Verified
Journal Article
Closed access
MSMurray B. Stein
Murray B. Stein
SJSonia Jain
Sonia Jain
NSNaomi M. Simon
Naomi M. Simon
JWJames C West
James C West
PMPaul J. Marvar
Paul J. Marvar
JMJulia Merker
Julia Merker

1 May 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
DMDebbie Madhok
Debbie Madhok
John K YueJohn K Yue
John K Yue
XSXiaoying Sun
Xiaoying Sun
CSCatherine G. Suen
Catherine G. Suen
NCNathan A. Coss
Nathan A. Coss
TIthe TRACK-TBI Investigators
the TRACK-TBI Investigators
A considerable subset of mild traumatic brain injury (mTBI) patients fail to return to baseline functional status at or beyond 3 months postinjury. Identifying at-risk patients for poor outcome in the emergency department (ED) may improve surveillance strategies and referral to care. Subjects with mTBI (Glasgow Coma Scale 13–15) and negative ED initial head CT < 24 h of injury, completing 3- or 6-month functional outcome (Glasgow Outcome Scale-Extended; GOSE), were extracted from the prospective, multicenter Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot study. Outcomes were dichotomized to full recovery (GOSE = 8) vs. functional deficits (GOSE < 8). Univariate predictors with p < 0.10 were considered for multivariable regression. Adjusted odds ratios (AOR) were reported for outcome predictors. Significance was assessed at p < 0.05. Subjects who completed GOSE at 3- and 6-month were 211 (GOSE < 8: 60%) and 185 (GOSE < 8: 65%). Risk factors for 6-month GOSE < 8 included less education (AOR = 0.85 per-year increase, 95% CI: (0.74–0.98)), prior psychiatric history (AOR = 3.75 (1.73–8.12)), Asian/minority race (American Indian/Alaskan/Hawaiian/Pacific Islander) (AOR = 23.99 (2.93–196.84)), and Hispanic ethnicity (AOR = 3.48 (1.29–9.37)). Risk factors for 3-month GOSE < 8 were similar with the addition of injury by assault predicting poorer outcome (AOR = 3.53 (1.17–10.63)). In mTBI patients seen in urban trauma center EDs with negative CT, education, injury by assault, Asian/minority race, and prior psychiatric history emerged as risk factors for prolonged disability.